| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc063274fd562feb683aac95474070d4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-20052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-205 |
| filingDate |
2017-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a277cfa390b70878e64f86abd0669f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d60f581ffd3a0e1bc7de9ca2ea198e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213b7b8598786dfe6cdbea7272f48ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ffc9496cf2fab2f43eb3364470e012b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a083e0f43647315db258543eeffc6ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886e30e53ab14e467ad89827e15a0fb9 |
| publicationDate |
2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190019776-A |
| titleOfInvention |
A serum-free suspension cells for producing rabies virus |
| abstract |
The present invention relates to a novel BHK-21 cell line derived from BHK-21 cells deposited as an ATCC CCL-34 cell line and capable of culturing in serum-free medium and adapted for suspension culture. The present invention also relates to a method for culturing the novel BHK-21 cell line and a method for producing rabies virus or viral antigen from the cell line. The present invention also relates to a vaccine composition for preventing, treating or preventing and treating rabies, which comprises rabies virus or viral antigen produced from the cell line. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022089350-A1 |
| priorityDate |
2017-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |